Randomized olmesartan and diabetes microalbuminuria prevention study (ROADMAP)

Trial Profile

Randomized olmesartan and diabetes microalbuminuria prevention study (ROADMAP)

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Jan 2017

At a glance

  • Drugs Olmesartan medoxomil (Primary)
  • Indications Cardiovascular disorders; Diabetic nephropathies; Hypertension in diabetes; Proteinuria
  • Focus Registrational; Therapeutic Use
  • Acronyms ROADMAP
  • Most Recent Events

    • 25 Sep 2013 Results of the pre-specified ECG analysis (n=1513) presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
    • 10 Mar 2011 Results published in the New England Journal of Medicine.
    • 24 Sep 2010 Results presented at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD), 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top